Breast cancer, menopause and yes, rhubarb

by JANE ALLIN October is National Breast Cancer Month. What better opportunity to remind women of the dangers posed by the use of HRT and the inherent cruelty foisted upon the innocent mares and their foals by the PMU industry? Despite advances in medical technology over the years, Pfizer continues to promote their conjugated equine… Continue reading Breast cancer, menopause and yes, rhubarb

Revenues from Premarin family of drugs falls 3% in 2016

by JANE ALLIN With a fall in prescriptions and market growth, revenues of the Premarin family of drugs have fallen 3% in 2016. So what does a 3% loss in the Premarin family of drugs represent? In 2015, as well as several years previously, these drugs netted about a billion US dollars. The question now… Continue reading Revenues from Premarin family of drugs falls 3% in 2016

FDA-Approved Alternatives to Premarin Derivatives – are they safer ?

by JANE ALLIN Contrary to popular belief, the FDA has yet to approve any generic as a substitute for Premarin and its daughter products (i.e. Prempro, Premphase, Duavee). Accordingly no prescription drugs used to treat menopausal symptoms, other than the Premarin family, contain pregnant mare’s urine. However much confusion arises when the subject of HRT… Continue reading FDA-Approved Alternatives to Premarin Derivatives – are they safer ?

Will federal legislation save American racing or help its horses? Don’t bet on it!

by JANE ALLIN On July 16, 2015 Congressmen Andy Barr (R-KY) and Paul Tonko (D-NY), the co-chairs of the Congressional Horse Caucus, introduced the bipartisan Thoroughbred Horseracing Integrity Act of 2015 (H.R. 3084). The rationale behind the legislation is to establish a solitary, impartial organization that would create and enforce uniform national anti-doping regulations for… Continue reading Will federal legislation save American racing or help its horses? Don’t bet on it!